Involving treatment paradigms for solid tumor cancers
- Reduces size of a tumor prior to initiation of additional therapies;
- Invasive to patient;
- Unable to kill microscopic disease.
- Targeted and localized treatment solution;
- Kills cells when delivered at high doses;
- Injures healthy tissues as well as cancer cells;
- Numerous potentially toxic side effects.
- Systemic treatment solution;
- Includes chemotherapy, targeted therapies and immuno-oncology;
- Many treatments target specific patient subgroups;
- Frequently accompanied by numerous side effects.
Autem gEM Device
Based on promising studies, we believe the device:
- Offers systemic palliative care treatment as monotherapy or in conjunction with standard of care;
- Induces anti-proliferative effects in HCC and other cancer cells, intracellular ionic kinetics interference, cellular metabolic alterations and mitotic spindle disruption;
- Is non-invasive and non-toxic;
- Treatment administration is out-patient once or twice a month.
The Autem gEM Device
We are developing the Autem gEM device, which we believe may offer an additional option for the palliative care treatment in patients with advanced cancer. The treatment can be administered as monotherapy or in conjunction to standard of care.
Treatment consists of using radio-frequency electromagnetic fields modulated at patient specific frequencies (PSF) which cause improvement in quality of life and may extend survival, besides showing anti-proliferative effects in cancer cells.
Electromagnetic radiation is a common field of energy that surrounds us all the time, and it can be modulated in amplitude at specific and very low frequencies.
We believe that electromagnetic field gradients, generated by the Autem gEM device, cause substantial dielectrophoretic forces on tubulin dimers, microtubules and mitochondria. This results in intracellular kinetic and metabolic alterations besides the disruption of the mitotic spindle in cancer cells during mitosis.
The Autem Medical Device
We are developing what we believe is innovative, non-invasive equipment which can be used as a palliative care treatment in patients with HCC and other cancers.